Invesco NASDAQ Biotech UCITS ETF (LON:SBIO)

Assets	441.02M
Expense Ratio	0.40%
PE Ratio	25.32
Forward PE	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	13,991
Open	77.14
Previous Close	76.47
Day's Range	76.63 - 77.31
52-Week Low	55.67
52-Week High	78.22
Beta	0.55
Holdings	1
Inception Date	Nov 6, 2014

About SBIO

Invesco NASDAQ Biotech UCITS ETF is an exchange traded fund launched by Source Investment Management Limited. The fund is managed by Assenagon Asset Management S.A. It invests in the public equity markets across the globe. The fund uses derivatives such as swaps to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sectors. It invests in the stocks of companies across all market capitalizations, with a minimum market capitalization of US $200 million. The fund seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing synthetic replication methodology. Invesco NASDAQ Biotech UCITS ETF was formed on November 6, 2014 and is domiciled in Ireland.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SBIO
• Provider: Invesco
• Index Tracked: NASDAQ / Biotechnology

Performance

SBIO had a total return of 39.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.94%.

Top Holdings

Name	Symbol	Weight
TRS NASDAQ Biotechnology TR USD	n/a	100.00%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Nov 11, 2026

Data Sources Report a data error